Clinical Trial Update: Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant carboplatin with weekly Abraxane and trastuzumab in HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: William Sikov MD | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-22